Spes Pharmaceuticals
Spes Pharmaceuticals Inc., a specialty biotech firm, develops and manufactures drugs and agricultural products.
Founded
2017Spes Pharmaceuticals Inc., a specialty biotech firm, develops and manufactures drugs and agricultural products.
Spes Pharmaceuticals Inc., founded in North Brunswick, NJ, is a specialty biotechnology firm dedicated to improving patient quality of life through innovative drug formulations. The company's core mission is to deliver medications that enhance safety, convenience, compliance, and efficacy. Spes Pharmaceuticals focuses on developing proprietary new formulations, transforming reconstitution/dilution products into ready-to-use dosage forms, and creating long-acting micro-particulate suspensions for extended-release injections.
Notable figures affiliated with Spes Pharmaceuticals include industry experts in biotechnology and pharmaceuticals, though specific names are not provided. The company has achieved significant milestones in developing its RTU (Ready-To-Use) and S4EIS (Solution System for Extended Release Injectable Suspension) technology platforms. These advancements have positioned Spes Pharmaceuticals as a key player in the specialty pharmaceutical market, contributing to better medication management and improved patient outcomes.
Companies similar to Spes Pharmaceuticals include US Specialty Formulations, Specialized Pharmaceuticalss, Scienture and Sonoran Biosciences.
Spes Pharmaceuticals was founded in 2017.
Spes Pharmaceuticals' headquarters is located in North Brunswick, NJ, US.
Spes Pharmaceuticals' most recent funding round was for $2M (USD) in June 2017.
As of Jun 20, 2017, Spes Pharmaceuticals has disclosed funding of $2M (USD). Undisclosed round amounts are excluded.
Spes Pharmaceuticals has 8 employees as of Feb 4, 2024.
Sonoran Biosciences
